SUZHOU, China – It is no secret that the fortunes of China's biotech sector have never looked brighter. There is a list of reasons – recent regulatory reforms, unwavering government financial support, vast amounts of venture capital, legions of young doctorates and a huge untapped market. But without cross-border partnering, China's biotech industry would look dramatically different.